Centchroman Regresses Mastalgia: A Randomized Comparison with Danazol

Preece PE, Mansel RE, Bolton PM, Hughes LE, Baum M, Gravelle IH (1976) Clinical syndromes of mastalgia. Lancet 2:670–3

Potten CS, Watson RJ, Williams GT et al (1988) The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58:163–70

Hughes LE, Mansel RE, Webster DJT (2000) Problems of concept and nomenclature of benign breast disease. Benign disorders and diseases of the breast, 2nd edn. Saunders, London, p 15

Asch RH, Greenblatt RB (1977) The use of an impeded androgen Danazol in the management of benign breast disorders. Am J Obstet Gynecol 127:130

Mansel RE, Preece PE, Hughes LE (1978) A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Brit J Surg 65:724–727

Fentiman IS, Caleffi M, Hamed H (1989) Dosage and duration of tamoxifen for mastalgia. A controlled trial. Br J Surg 76:901–904

Mansel RE, Goyal A, Preece P, Leinster S, Maddox PR, Gateley C, Kubista E, von Fournier D (2004) European randomized, multicenter study of goserline (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 191(6):1942–9

Colak T, Ipek T, Kanik A, Ogetman Z, Aydin S (2003) Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 196(4):525–30

Barros AC, Mottola J, Ruiz CA (1999) Reassurance in the treatment of mastalgia. Breast J 5:162

Hadi MS (2000) Sports Brassiere; Is it a solution for mastalgia? Breast J 6:407

Minton JP, Foeking MK, Webster DJT et al (1979) Response of fibrocystic disease to caffeine withdrawal and correlation with cystic nucleotides with breast disease. Am J Obstet Gynecol 135:157

Goyal A, Mansel RE (2005) A randomized multicenter study of gamolenic acid with and without, antioxidants, vitamins and minerals in the management of mastalgia. Breast J 11:41–47

Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, Chabra A (2007) Evidence based management of Mastalgia: a meta-analysis of randomized trials. Breast 16:503–12

Hughes LE, Mansel RE, Webster DJT (2000) Problems of concept and nomenclature of benign breast disease. Benign Disorders and Diseases of the Breast, 2nd edn. Saunders, London, p 108

Mansel RE, Preece PE, Huges LE (1978) A double blind trial of prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg 65:724–727

Messinis LE, Lolis D (1988) Treatment of Premenstrual Mastalgia with Tamoxifen. Acta Obstet Gynecol Scand 67:307–309

Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1(8476):287–8

Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D (1997) Comparison of Tamoxifen with Danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 11:393–397

Singh MM, Centchroman (2001) A selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorder. Med Res Rev 21(4):302–347

Kamboj VP, Setty BS, Chandra H, Roy SK, Kar AB (1977) Biological profile of Centchroman—a new post-coital contraceptive. Indian J Exp Biol 15:1144–1150

Vaidya R, Joshi U, Meherji P, Rege N, Betrabet S, Joshi L, Sheth A, Devi PK (1977) Centchroman in healthy female volunteers. Indian J Exp Biol 15:1173–1176

Centchroman (1991) Multicentric trial with biweekly cum weekly dose. Central Drug Research Institute, Lucknow

Lal J (2010) Clinical pharmacokinetics and interaction of Centchroman- a mini review. Contraception. doi: 10.1016/j.contraception.2009.11.007

Dhar A, Srivastava A (2007) Role of centchroman in regression of Mastalgia and Fibroadenoma. World J Surg 31:1178–84